CellFE, Inc. Market Research Report



Company Overview


  • Name: CellFE, Inc.

  • Mission: To create a world where everyone has access to lifesaving cell therapies.

  • Year Founded: No information is available

  • Founders: No information is available

  • Key People:

  • Alla Zamarayeva, PhD - CEO & Co-founder

  • Todd Sulchek, PhD - CSO & Co-founder

  • Andrew Levitch - CFO

  • Alex Alexeev, PhD - CTO & Co-founder

  • Leo Fomin - VP of Product Development

  • Sewoon Han, PhD - Head of Engineering

  • Paul Carman - Head of Sales

  • Chih-Wen Ni, PhD - Head of Science

  • Headquarters: 1000 Atlantic Ave., Suite 104, Alameda, CA 94501

  • Number of Employees: No information is available

  • Revenue: No information is available

  • Notable for: Developing the Infinity MTx platform, a microfluidics-based cellular engineering technology for research and process development of cell therapies.


Products


Infinity MTx Platform


  • Product Description:

  • The Infinity MTxTM instrument is a benchtop device designed for research and process development of cell therapies using microfluidics technology.

  • Key Features:

  • Gentle Process: Ensures engineered cells remain healthy and recover quickly for downstream applications.

  • Reliable Delivery: Transfects challenging cell types with a variety of payloads.

  • Exceptional Performance: High yields of transfected cells with robust proliferative capacity.

  • Streamlined Workflow: Easy optimization without the need for specific media, buffers, or chemical additives.

  • Small Footprint: Fits inside a biological safety cabinet or on a laboratory benchtop.

  • Rapid Processing: Samples are processed in less than 10 milliseconds.

  • User-Friendly: Plug-and-play setup with intuitive software for creating and editing protocols.

  • Flexible: Processes up to eight samples in one run.

  • Convenient: Includes bar code reader, NFC tag, and features for run history analysis.


Infinity MPAs (Microfluidic Processing Assemblies)


  • Product Description:

  • Designed for use with the Infinity MTx instrument, each MPA includes eight single-use processing units.

  • Key Features:

  • Optimize Your Protocol: Infinity Optimizer MPA consists of processing units with varying ridge gap sizes to optimize protocols.

  • Scale with Consistency: Standard Infinity MPA uses microfluidic chips with single ridge gap sizes for standard protocols once optimized.


Recent Developments


New Partnerships and Financial Milestones:


  • Series A Financing:

  • Raised $22 million in Series A financing led by M Ventures, with participation from Great Point Ventures, Riverine Ventures, and existing investors.


Events and Presentations:


  • May 2024 Conference:

  • CEO Alla Zamarayeva, PhD, to present at the International Society of Gene & Cell Therapy (ISCT) Annual Meeting from May 29-June 1, 2024, in Vancouver, BC.

  • CSO Todd Sulchek, PhD, to present at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting from May 7-11, 2024, in Baltimore, MD.

  • BIO2022:

  • Unveiled research scale microfluidics-based cell engineering platform at the BIO International Convention.


Product and Technology Enhancement:


  • Infinity Platform Development:

  • Continued innovation in microfluidics technology to support high yields, scalability, superior cell health, and complex genome editing without the need for viral vectors.


Team Expansion:


  • Board of Directors:

  • Mike Rice, a veteran in life science tools, has joined the board of directors.


Key Impact Metrics


  • Viability: >90% with superior cell health and functionality.

  • Payload Delivery: 10+ kb for any cell type.

  • Scalability: From 1 million to billions of cells, scaling from discovery to commercial manufacturing.

  • Processing Time: 1-2 days, including complex editing.

  • Viral Vectors: No viral vectors required.


Intellectual Property


  • Patents:

  • US 10717084

  • US 11198127

  • US 11268892

  • US 11668638

  • US 11788050

  • US 11925934

  • US 8356714

  • CN 110198785

  • CN 117015596

  • JP 7084393


Contact Information


  • Address:

  • CellFE, Inc.

  • 1000 Atlantic Ave., Suite 104

  • Alameda, CA 94501

  • Email: info@cellfebiotech.com


© 2024 CellFE, Inc. All rights reserved.
Privacy Policy | Terms of Use